583 related articles for article (PubMed ID: 33161452)
1. Optimizing antiemetic treatment for chemotherapy-induced nausea and vomiting in Japan: Update summary of the 2015 Japan Society of Clinical Oncology Clinical Practice Guidelines for Antiemesis.
Aogi K; Takeuchi H; Saeki T; Aiba K; Tamura K; Iino K; Imamura CK; Okita K; Kagami Y; Tanaka R; Nakagawa K; Fujii H; Boku N; Wada M; Akechi T; Iihara H; Ohtani S; Okuyama A; Ozawa K; Kim YI; Sasaki H; Shima Y; Takeda M; Nagasaki E; Nishidate T; Higashi T; Hirata K
Int J Clin Oncol; 2021 Jan; 26(1):1-17. PubMed ID: 33161452
[TBL] [Abstract][Full Text] [Related]
2. Japanese Society of Clinical Oncology clinical practice guidelines 2010 for antiemesis in oncology: executive summary.
Takeuchi H; Saeki T; Aiba K; Tamura K; Aogi K; Eguchi K; Okita K; Kagami Y; Tanaka R; Nakagawa K; Fujii H; Boku N; Wada M; Akechi T; Udagawa Y; Okawa Y; Onozawa Y; Sasaki H; Shima Y; Shimoyama N; Takeda M; Nishidate T; Yamamoto A; Ikeda T; Hirata K
Int J Clin Oncol; 2016 Feb; 21(1):1-12. PubMed ID: 26081252
[TBL] [Abstract][Full Text] [Related]
3. Testing the effectiveness of antiemetic guidelines: results of a prospective registry by the CINV Study Group of Japan.
Tamura K; Aiba K; Saeki T; Nakanishi Y; Kamura T; Baba H; Yoshida K; Yamamoto N; Kitagawa Y; Maehara Y; Shimokawa M; Hirata K; Kitajima M;
Int J Clin Oncol; 2015 Oct; 20(5):855-65. PubMed ID: 25681876
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the validity of chemotherapy-induced nausea and vomiting assessment in outpatients using the Japanese version of the MASCC antiemesis tool.
Matsuda Y; Okita K; Furuhata T; Kutomi G; Yamashita K; Sato Y; Takimoto R; Hirata K
Support Care Cancer; 2015 Nov; 23(11):3331-9. PubMed ID: 26003425
[TBL] [Abstract][Full Text] [Related]
5. Changes in compliance with Japanese antiemetic guideline for chemotherapy-induced nausea and vomiting: a nationwide survey using a distributed research network.
Hori K; Kobayashi N; Atsumi H; Nagayama A; Kondoh M; Noge I; Kimura M; Utsugi H; Iwasaki T; Nakamura M; Kimura T
Support Care Cancer; 2014 Apr; 22(4):969-77. PubMed ID: 24276954
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of antiemetic practices for prevention of chemotherapy-induced nausea and vomiting (CINV): results of a European oncology nurse survey.
Dielenseger P; Börjeson S; Vidall C; Young A; Jahn P
Support Care Cancer; 2019 Nov; 27(11):4099-4106. PubMed ID: 30783815
[TBL] [Abstract][Full Text] [Related]
7. Chemotherapy-induced nausea and vomiting (CINV) and adherence to antiemetic guidelines: results of a survey of oncology nurses.
Clark-Snow R; Affronti ML; Rittenberg CN
Support Care Cancer; 2018 Feb; 26(2):557-564. PubMed ID: 28871358
[TBL] [Abstract][Full Text] [Related]
8. Avoidable Acute Care Use Associated with Nausea and Vomiting Among Patients Receiving Highly Emetogenic Chemotherapy or Oxaliplatin.
Navari RM; Ruddy KJ; LeBlanc TW; Nipp R; Clark-Snow R; Schwartzberg L; Binder G; Bailey WL; Potluri R; Schmerold LM; Papademetriou E; Roeland EJ
Oncologist; 2021 Apr; 26(4):325-331. PubMed ID: 33289268
[TBL] [Abstract][Full Text] [Related]
9. A Nationwide, Multicenter Registry Study of Antiemesis for Carboplatin-Based Chemotherapy-Induced Nausea and Vomiting in Japan.
Iihara H; Shimokawa M; Hayashi T; Kawazoe H; Saeki T; Aiba K; Tamura K
Oncologist; 2020 Feb; 25(2):e373-e380. PubMed ID: 32043774
[TBL] [Abstract][Full Text] [Related]
10. The compliance with antiemetic guidelines of Turkish medical oncologists. A survey study of Turkish Oncology Group.
Araz M; Karaagac M; Korkmaz L; Beypinar I; Uysal M
Curr Probl Cancer; 2019 Aug; 43(4):344-353. PubMed ID: 30497851
[TBL] [Abstract][Full Text] [Related]
11. Factors affecting the implementation of guideline-based prophylactic antiemetic therapy for chemotherapy-induced nausea and vomiting in Japan: a protocol for a hospital-based qualitative study.
Yaguchi-Saito A; Kaji Y; Matsuoka A; Okuyama A; Fujimori M; Saito J; Odawara M; Otsuki A; Uchitomi Y; Zenda S; Shimazu T
BMJ Open; 2022 Jun; 12(6):e055473. PubMed ID: 35667723
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of Adherence to Antiemetic Treatment Guidelines in Patients With Chemotherapy-Induced Nausea and Vomiting in Teaching Hospitals in Tehran.
Nikbakht Z; Rajabi M; Shahrasbi A; Roohi E; Hashemian F
J Cancer Educ; 2021 Oct; 36(5):1022-1029. PubMed ID: 31955393
[TBL] [Abstract][Full Text] [Related]
13. The cost of antiemetic therapy for chemotherapy-induced nausea and vomiting in patients receiving platinum-containing regimens in daily practice in Japan: a retrospective study.
Hamada S; Hinotsu S; Hori K; Furuse H; Oikawa T; Kawakami J; Ozono S; Akaza H; Kawakami K
Support Care Cancer; 2012 Apr; 20(4):813-20. PubMed ID: 21472498
[TBL] [Abstract][Full Text] [Related]
14. Cancer and chemotherapy-induced nausea and vomiting: a focus on olanzapine.
Bosnjak SM; Dimitrijevic J; Djordjevic F
Curr Opin Support Palliat Care; 2016 Jun; 10(2):180-8. PubMed ID: 27028050
[TBL] [Abstract][Full Text] [Related]
15. Oncologist perspectives on chemotherapy-induced nausea and vomiting (CINV) management and outcomes: A quantitative market research-based survey.
Aapro M; Ruffo P; Panteri R; Costa S; Piovesana V
Cancer Rep (Hoboken); 2018 Dec; 1(4):e1127. PubMed ID: 32729252
[TBL] [Abstract][Full Text] [Related]
16. [Treatment of tumor therapy-induced nausea and vomiting].
Pikó B; Bassam A
Magy Onkol; 2009 Mar; 53(1):39-45. PubMed ID: 19318325
[TBL] [Abstract][Full Text] [Related]
17. State of the Art Antiemetic Therapy for Cancer Patients.
Lau TK; Yip CH; Yeo W
Curr Oncol Rep; 2016 Jan; 18(1):2. PubMed ID: 26694923
[TBL] [Abstract][Full Text] [Related]
18. A retrospective review of antiemetic use for chemotherapy-induced nausea and vomiting in pediatric oncology patients at a tertiary care center.
Aseeri M; Mukhtar A; Al Khansa S; Elimam N; Jastaniah W
J Oncol Pharm Pract; 2013 Jun; 19(2):138-44. PubMed ID: 23034405
[TBL] [Abstract][Full Text] [Related]
19. Chemotherapy-induced nausea and vomiting is less controlled at delayed phase in patients with esophageal cancer: a prospective registration study by the CINV Study Group of Japan.
Baba Y; Baba H; Yamamoto S; Shimada H; Shibata T; Miyazaki T; Yoshikawa T; Nakajima Y; Tsuji Y; Shimokawa M; Kitagawa Y; Aiba K
Dis Esophagus; 2017 Feb; 30(2):1-7. PubMed ID: 27001532
[TBL] [Abstract][Full Text] [Related]
20. Treatment of breakthrough and prevention of refractory chemotherapy-induced nausea and vomiting in pediatric cancer patients: Clinical practice guideline update.
Patel P; Robinson PD; Phillips R; Baggott C; Devine K; Gibson P; Guilcher GMT; Holdsworth MT; Neumann E; Orsey AD; Spinelli D; Thackray J; van de Wetering M; Cabral S; Sung L; Dupuis LL
Pediatr Blood Cancer; 2023 Aug; 70(8):e30395. PubMed ID: 37178438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]